CASELLI, Emilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.597
EU - Europa 3.134
AS - Asia 1.910
SA - Sud America 211
AF - Africa 35
OC - Oceania 4
Totale 10.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.556
IT - Italia 860
GB - Regno Unito 766
SG - Singapore 559
CN - Cina 514
SE - Svezia 488
HK - Hong Kong 385
DE - Germania 223
BR - Brasile 186
RU - Federazione Russa 178
UA - Ucraina 143
KR - Corea 96
FR - Francia 86
TR - Turchia 85
FI - Finlandia 79
VN - Vietnam 67
BG - Bulgaria 62
IN - India 52
IE - Irlanda 48
ID - Indonesia 44
BE - Belgio 42
NL - Olanda 41
CA - Canada 29
RO - Romania 28
JP - Giappone 26
ES - Italia 25
BD - Bangladesh 17
AT - Austria 15
PL - Polonia 15
MY - Malesia 10
LT - Lituania 9
ZA - Sudafrica 9
IQ - Iraq 8
MA - Marocco 8
CL - Cile 7
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DZ - Algeria 5
MX - Messico 5
SC - Seychelles 5
VE - Venezuela 5
CH - Svizzera 4
TW - Taiwan 4
UZ - Uzbekistan 4
AR - Argentina 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
AL - Albania 2
AU - Australia 2
BY - Bielorussia 2
EE - Estonia 2
KG - Kirghizistan 2
LB - Libano 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MT - Malta 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
ZM - Zambia 1
Totale 10.891
Salva come PNG Salva come JPEG
Città #
Santa Clara 745
Chandler 517
Fairfield 474
Woodbridge 448
Southend 419
Ashburn 387
Hong Kong 379
Singapore 319
Jacksonville 298
Ann Arbor 263
Nyköping 262
Houston 229
Dearborn 206
London 203
Cambridge 192
Seattle 192
Wilmington 182
Modena 167
Hefei 138
Beijing 86
Princeton 61
Sofia 61
San Diego 53
Redwood City 52
Milan 50
Eugene 48
Des Moines 47
Dublin 46
Izmir 41
Seoul 39
Shanghai 39
Jakarta 38
Reggio Emilia 37
Moscow 36
Brussels 35
Council Bluffs 35
Parma 31
New York 29
Munich 28
Helsinki 27
Los Angeles 23
Bologna 22
Amsterdam 21
Florence 21
Hanoi 21
Timisoara 21
Frankfurt am Main 20
Falls Church 19
Menlo Park 19
Columbus 18
Pedara 18
Boardman 17
Fuzhou 17
Nuremberg 17
Turin 17
Bremen 16
Fremont 16
São Paulo 16
The Dalles 16
Formigine 15
Seongnam 15
Dong Ket 14
Norwalk 13
Ho Chi Minh City 12
Kunming 11
Nanjing 11
Guangzhou 10
Phoenix 10
Verona 10
Washington 10
Cardiff 9
Dallas 9
Tokyo 9
Trento 9
Bagheria 8
Pune 8
San Francisco 8
Turku 8
Ventimiglia 8
Barcelona 7
Brooklyn 7
Kilburn 7
Las Vegas 7
Lentate sul Seveso 7
Loano 7
Podenzano 7
Rome 7
Toronto 7
Vienna 7
Bibbiano 6
Boston 6
Carpi 6
Castell'arquato 6
Chicago 6
Girona 6
Groningen 6
Ottawa 6
Potenza Picena 6
Putian 6
Salvador 6
Totale 7.637
Salva come PNG Salva come JPEG
Nome #
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening 692
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 389
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 286
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 272
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 264
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 263
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 243
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 236
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 235
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 233
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 229
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 229
Chemo-enzymatic synthesis of levodropropizine 217
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 209
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 201
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 196
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 193
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 192
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 190
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 190
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 189
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 187
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 185
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 184
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 181
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 181
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 179
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 174
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 171
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 169
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 165
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 165
Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase 163
Using Boronic Acid Transition State Inhibitors to understand the extended spectrum (ES) and carbapenemase phenotypes of class A beta-lactamases in Klebsiella pneumoniae 162
Exploring novel inhibitors of FOX-4 Class C β-lactamase 152
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase 150
Stereoselective synthesis of erythro beta-substituted aspartates 149
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases 149
Nanomolar inhibitors of AmpC beta-lactamase 148
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 148
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 148
Structures of FOX-4 cephamycinase in complex with transition-state analog inhibitors 145
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 142
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 139
Structure-Based Design and In Parallel Synthesis of Boronic Acid Inhibitors of AmpC 61538;-Lactamase 138
Structure-based optimization of cephalotin analogue boronic acids as beta-lactamase inhibitors 134
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design 134
Recognition and resistance in TEM beta-lactamase 132
Structure-based design and solid phase synthesis of novel AmpC b-lactamase inhibitors 129
Progettazione, Sintesi ed Attività di Acidi 1-Acilamminoalcanboronici Inibitori di beta-Lattamasi 125
Interactions of Oxyimino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42 124
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs 122
The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV β-lactamase: A study of Ambler position Asn276 113
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 108
Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog 108
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii 99
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum 90
Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor 90
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 68
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates 67
Structural Studies of Inhibition of β-Lactamases by Boronic Acid Transition State Analogs and a Penam Sulfone 63
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas-derived cephalosporinase 47
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry 22
Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030 12
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb) 11
Totale 11.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.230
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.544 116 40 130 124 194 171 119 139 124 201 107 79
2021/20221.248 81 116 86 106 68 109 48 88 144 88 187 127
2022/20231.532 186 174 113 161 173 222 38 120 180 20 55 90
2023/2024988 38 76 49 104 186 92 143 78 26 32 53 111
2024/20253.060 110 65 70 178 536 456 205 228 301 84 337 490
2025/202692 92 0 0 0 0 0 0 0 0 0 0 0
Totale 11.020